Our Recommendations
New Publications
- Modelling historical changes in the force-of-infection of Chagas disease to inform control and elimination programmes: application in Colombia (2022)
- Chagas Clinical Research Platform Newsletter (2022)
- The multidimensional comprehension of Chagas disease (2022)
- New Therapeutics for Chagas Disease: Charting a Course to Drug Approval (2022)
- Diagnosis and Clinical Management of Chagas Disease: An Increasing Challenge in Non-Endemic Areas (2022)
Filter
45
Featured
Recommendations
1
Language
Document type
Studies & Reports
35
Resource Platforms
5
Fact sheets
2
Guidelines
1
Strategic & Response Plan
1
No document type
1
Countries / Regions
Global
7
Colombia
5
Latin America and the Carribbean
4
Paraguay
2
Mexico
1
El Salvador
1
Authors & Publishers
Publication Years
Category
Studies & Reports
5
Chagas
3
Toolboxes
Transmission of Chagas disease (CD) has decreased in recent decades, but the disease remains an important problem in endemic areas. There was an increase in the proportion of nonvector transmission, mainly in nonendemic countries. The aim of this study was to gather evidence concerning healthcare pr...
Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is an appropriate time to celebrate what has been ach...
Carlos Chagas discovered American trypanosomiasis, also named Chagas disease (CD) in his honor, just over a century ago. He described the clinical aspects of the disease, characterized by its etiological agent (Trypanosoma cruzi) and identified its insect vector. Initially, CD occurred only in Latin...
Chagas disease, which is caused by infection with the parasite Trypanosoma cruzi, is known as the silent disease. An estimated 8 million people have the disease and most of them do not know that they are infected.
A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data platform.
Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations s...
